Research programme: mGluR2 modulators - Addex Pharmaceuticals/Ortho-McNeil

Drug Profile

Research programme: mGluR2 modulators - Addex Pharmaceuticals/Ortho-McNeil

Alternative Names: ADX 92639; JNJ-40068782

Latest Information Update: 07 Dec 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Addex Pharmaceuticals; Ortho-McNeil
  • Developer Addex Therapeutics; IRCCS Neuromed Mediterranean Neurological Institute; Ortho-McNeil
  • Class Small molecules
  • Mechanism of Action Metabotropic glutamate receptor 2 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cognition disorders; Major depressive disorder; Stroke
  • Discontinued Anxiety disorders; Schizophrenia

Most Recent Events

  • 07 Dec 2016 Discontinued - Preclinical for Anxiety disorders in Europe (unspecified route)
  • 07 Dec 2016 Discontinued - Preclinical for Schizophrenia in Europe (unspecified route)
  • 07 Dec 2016 Preclinical trials in Cognition disorders in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top